Krystal Biotech stock trades on Nasdaq, and Citigroup provides analyst ratings and price targets for the company.
2 reports, 1 independent
Updated Jul 29
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Krystal Biotech stock trades on Nasdaq, and Citigroup provides analyst ratings and price targets for the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Krystal Biotech, Inc.
biotechnology company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
-
Citigroup
American investment bank and financial services corporation
Related events
- Krystal Biotech stock is seeing increased institutional investment activity, with related filings made on the SEC regarding its trading on the Nasdaq exchange.
- Citigroup provided analyst ratings and reports for ServiceTitan stock, which trades on Nasdaq.
- Keefe, Bruyette & Woods provides analyst ratings for Citigroup stock.
- Insider sales of Krystal Biotech stock were disclosed to the SEC by executives.
- Australia-based biotechnology company Novogen Limited is now trading on the Nasdaq stock exchange.